why choose us

First received: December 11, 2024

Clinical Trial: Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute-On-Chronic Liver Failure

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Allogeneic Human Bone Marrow Mesenchymal Stem Cells for the Treatment of Patients With Acute-on-chronic Liver Failure

Brief Summary: The goal of this clinical trial is to learn if CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection (hereinafter referred to as CG-BM1) can treat acute-on-chronic liver failure (ACLF) patients. Main purposes of this clinical trial are:* To evaluate the safety and tolerability of CG-BM1 for the treatment of adult patients with ACLF.* To observe the preliminary effectiveness of CG-BM1 in treating adult ACLF patients, and to provide a basis for subsequent clinical trial protocol design.

Read more